Pfizer's SU 11248 has been granted orphan drug status by the European Commission

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1475, 2005-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The European Commission has granted orphan drug designation to CytRx Corporation's arimoclomol for the treatment of amyotrophic lateral sclerosis

Inpharma, Vol. 1, Iss. 1563, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Nimotuzumab [Theraloc] granted orphan drug status in Europe.

Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Rexin-G granted orphan drug status for third indication in US.

Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

The EMEA has granted Orphan Drug Designation for imisopasem manganese [M40403; ActivBiotics] for the prevention of oral mucositis

Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Injectable fomepizole [`Antizol'; Paladin Labs] has been granted priority review status in Canada

Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite